NCT05306054

Brief Summary

The purpose of this study is to investigate the association between time spent in moderate to vigorous physical activity and markers of cartilage metabolism in the years following anterior cruciate ligament reconstruction.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 21, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 31, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

March 15, 2024

Status Verified

March 1, 2024

Enrollment Period

1.9 years

First QC Date

March 21, 2022

Last Update Submit

March 12, 2024

Conditions

Keywords

Physical ActivityKnee Joint LoadingCumulative LoadBiomarkersMusculoskeletal ModellingPatient Reported Outcomes

Outcome Measures

Primary Outcomes (1)

  • Ratio of urine concentration of c-telopeptide of type II collagen to serum concentration of c-propeptide of type II procollagen

    Urine concentration of c-telopeptide of type II collagen (uCTX-II) is a marker of cartilage degradation. Serum concentration of c-propeptide of type II procollagen (sCP-II) is a marker of cartilage synthesis. The ratio between these two biomarkers as an indicator of knee joint health has previously been validated.

    Day 1

Secondary Outcomes (19)

  • Urine concentration of c-telopeptide of type II collagen

    Day 1

  • Serum concentration of c-propeptide of type II procollagen

    Day 1

  • Time spent in moderate to vigorous physical activity

    Day 3-10

  • Step count

    Day 3-10

  • Knee joint reaction force

    Day 11

  • +14 more secondary outcomes

Study Arms (2)

Intra-Articular Knee Injury

Forty men and women aged 18-45 years old who are 1-7 years following an intra-articular knee injury.

Controls

Forty men and women aged 18-45 years old who are matched to the injured group by age, sex and body mass index.

Eligibility Criteria

Age18 Years - 39 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Young men and women who are aged 18-39 years old and are 1-7 years following their anterior cruciate ligament injury and surgery.

You may qualify if:

  • years old (i.e., ≥18 and \<40 years old)
  • Had an anterior cruciate ligament injury and reconstruction 1-7 years ago (i.e., ≥1 and ≤7 years ago)
  • Can have sustained damage to meniscus or cartilage, or sustained bone bruising when injured anterior cruciate ligament
  • Can participate regardless of the type of reconstruction surgery and if undergone meniscectomy
  • Completed anterior cruciate ligament reconstruction rehabilitation and either a surgeon, doctor or physiotherapist has provided clearance to participate in physical activity
  • Be able to attend the University of Bath within 2 hours of waking

You may not qualify if:

  • Had another significant knee injury either before, at the same time, or after the anterior cruciate ligament injury (e.g., if they injured another ligament in their knee or had a fracture or dislocation)
  • Injured the anterior cruciate ligament in both knees (bilateral ACL injury)
  • Have/are experiencing a musculoskeletal, cardiovascular, respiratory, immune, metabolic or neurological disease or disorder
  • Under 18 or over 39 (i.e., ≥40) years of age
  • Body Mass Index ≥40 kg/m²
  • Pregnancy
  • Positive responses to the Physical Activity Readiness Questionnaire (aside from any involved knee joint issues)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Bath

Bath, United Kingdom

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood Serum and Plasma. Urine.

MeSH Terms

Conditions

Anterior Cruciate Ligament InjuriesMotor Activity

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and InjuriesBehavior

Study Officials

  • Karl Morgan, MSc

    University of Bath

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Karl Morgan, MSc

CONTACT

Jean-Philippe Walhin, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Investigator

Study Record Dates

First Submitted

March 21, 2022

First Posted

March 31, 2022

Study Start

June 1, 2022

Primary Completion

May 1, 2024

Study Completion

July 1, 2024

Last Updated

March 15, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations